WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsZhongchao Inc (ZCMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 21901% more annual revenue ($2.89B vs $13.12M). MMED leads profitability with a -7.3% profit margin vs -13.0%. MMED earns a higher WallStSmart Score of 37/100 (F).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

ZCMD

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 9.29

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

ZCMD3 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.2910/10

Safe zone — low bankruptcy risk

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

ZCMD4 concerns · Avg: 2.3/10
Market CapQuality
$6.96M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-5.9%2/10

ROE of -5.9% — below average capital efficiency

Revenue GrowthGrowth
-32.9%2/10

Revenue declined 32.9%

EPS GrowthGrowth
-91.0%2/10

Earnings declined 91.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : ZCMD

The strongest argument for ZCMD centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : ZCMD

The primary concerns for ZCMD are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

MMED is growing revenue faster at 13.1% — sustainability is the question.

ZCMD generates stronger free cash flow (2M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 29/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Zhongchao Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · China

Zhongchao Inc. provides health care information, education and training services in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?